A citation-based method for searching scientific literature

Yuefei Zhu, Jia Li, Zhiqing Pang. Asian J Pharm Sci 2021
Times Cited: 17







List of co-cited articles
94 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Markus Hoffmann, Hannah Kleine-Weber, Simon Schroeder, Nadine Krüger, Tanja Herrler, Sandra Erichsen, Tobias S Schiergens, Georg Herrler, Nai-Huei Wu, Andreas Nitsche,[...]. Cell 2020
35

A pneumonia outbreak associated with a new coronavirus of probable bat origin.
Peng Zhou, Xing-Lou Yang, Xian-Guang Wang, Ben Hu, Lei Zhang, Wei Zhang, Hao-Rui Si, Yan Zhu, Bei Li, Chao-Lin Huang,[...]. Nature 2020
29

Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV.
Timothy P Sheahan, Amy C Sims, Sarah R Leist, Alexandra Schäfer, John Won, Ariane J Brown, Stephanie A Montgomery, Alison Hogg, Darius Babusis, Michael O Clarke,[...]. Nat Commun 2020
828
29

A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.
Bin Cao, Yeming Wang, Danning Wen, Wen Liu, Jingli Wang, Guohui Fan, Lianguo Ruan, Bin Song, Yanping Cai, Ming Wei,[...]. N Engl J Med 2020
23

Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys.
Travis K Warren, Robert Jordan, Michael K Lo, Adrian S Ray, Richard L Mackman, Veronica Soloveva, Dustin Siegel, Michel Perron, Roy Bannister, Hon C Hui,[...]. Nature 2016
715
23

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.
Manli Wang, Ruiyuan Cao, Leike Zhang, Xinglou Yang, Jia Liu, Mingyue Xu, Zhengli Shi, Zhihong Hu, Wu Zhong, Gengfu Xiao. Cell Res 2020
23

The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.
Yan-Rong Guo, Qing-Dong Cao, Zhong-Si Hong, Yuan-Yang Tan, Shou-Deng Chen, Hong-Jun Jin, Kai-Sen Tan, De-Yun Wang, Yan Yan. Mil Med Res 2020
17

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.
Dawei Wang, Bo Hu, Chang Hu, Fangfang Zhu, Xing Liu, Jing Zhang, Binbin Wang, Hui Xiang, Zhenshun Cheng, Yong Xiong,[...]. JAMA 2020
17

Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors.
Linlin Zhang, Daizong Lin, Xinyuanyuan Sun, Ute Curth, Christian Drosten, Lucie Sauerhering, Stephan Becker, Katharina Rox, Rolf Hilgenfeld. Science 2020
17

Remdesivir for the Treatment of Covid-19 - Final Report.
John H Beigel, Kay M Tomashek, Lori E Dodd, Aneesh K Mehta, Barry S Zingman, Andre C Kalil, Elizabeth Hohmann, Helen Y Chu, Annie Luetkemeyer, Susan Kline,[...]. N Engl J Med 2020
17

Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases.
Cynthia Liu, Qiongqiong Zhou, Yingzhu Li, Linda V Garner, Steve P Watkins, Linda J Carter, Jeffrey Smoot, Anne C Gregg, Angela D Daniels, Susan Jervey,[...]. ACS Cent Sci 2020
524
17

The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro.
Leon Caly, Julian D Druce, Mike G Catton, David A Jans, Kylie M Wagstaff. Antiviral Res 2020
765
17


A new coronavirus associated with human respiratory disease in China.
Fan Wu, Su Zhao, Bin Yu, Yan-Mei Chen, Wen Wang, Zhi-Gang Song, Yi Hu, Zhao-Wu Tao, Jun-Hua Tian, Yuan-Yuan Pei,[...]. Nature 2020
17

Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir.
Egor P Tchesnokov, Joy Y Feng, Danielle P Porter, Matthias Götte. Viruses 2019
274
17


Compassionate Use of Remdesivir for Patients with Severe Covid-19.
Jonathan Grein, Norio Ohmagari, Daniel Shin, George Diaz, Erika Asperges, Antonella Castagna, Torsten Feldt, Gary Green, Margaret L Green, François-Xavier Lescure,[...]. N Engl J Med 2020
17

Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses.
Dustin Siegel, Hon C Hui, Edward Doerffler, Michael O Clarke, Kwon Chun, Lijun Zhang, Sean Neville, Ernest Carra, Willard Lew, Bruce Ross,[...]. J Med Chem 2017
284
17

Candidate drugs against SARS-CoV-2 and COVID-19.
Dwight L McKee, Ariane Sternberg, Ulrike Stange, Stefan Laufer, Cord Naujokat. Pharmacol Res 2020
230
17

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.
Yeming Wang, Dingyu Zhang, Guanhua Du, Ronghui Du, Jianping Zhao, Yang Jin, Shouzhi Fu, Ling Gao, Zhenshun Cheng, Qiaofa Lu,[...]. Lancet 2020
17

Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths.
Chih-Cheng Lai, Yen Hung Liu, Cheng-Yi Wang, Ya-Hui Wang, Shun-Chung Hsueh, Muh-Yen Yen, Wen-Chien Ko, Po-Ren Hsueh. J Microbiol Immunol Infect 2020
380
11

Effective treatment of severe COVID-19 patients with tocilizumab.
Xiaoling Xu, Mingfeng Han, Tiantian Li, Wei Sun, Dongsheng Wang, Binqing Fu, Yonggang Zhou, Xiaohu Zheng, Yun Yang, Xiuyong Li,[...]. Proc Natl Acad Sci U S A 2020
11

COVID-19: The Potential Role of Copper and N-acetylcysteine (NAC) in a Combination of Candidate Antiviral Treatments Against SARS-CoV-2.
Andri Andreou, Sofia Trantza, Demetrios Filippou, Nikolaos Sipsas, Sotirios Tsiodras. In Vivo 2020
36
11

Lung Protection by Cathepsin C Inhibition: A New Hope for COVID-19 and ARDS?
Brice Korkmaz, Adam Lesner, Sylvain Marchand-Adam, Celia Moss, Dieter E Jenne. J Med Chem 2020
18
11


Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment.
Mehmet Soy, Gökhan Keser, Pamir Atagündüz, Fehmi Tabak, Işık Atagündüz, Servet Kayhan. Clin Rheumatol 2020
263
11

Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19.
Xiaoyan Liu, Zhe Li, Shuai Liu, Jing Sun, Zhanghua Chen, Min Jiang, Qingling Zhang, Yinghua Wei, Xin Wang, Yi-You Huang,[...]. Acta Pharm Sin B 2020
107
11


Arbidol: a broad-spectrum antiviral compound that blocks viral fusion.
Y S Boriskin, I A Leneva, E-I Pécheur, S J Polyak. Curr Med Chem 2008
198
11

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.
Roujian Lu, Xiang Zhao, Juan Li, Peihua Niu, Bo Yang, Honglong Wu, Wenling Wang, Hao Song, Baoying Huang, Na Zhu,[...]. Lancet 2020
11

Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors.
Zhenming Jin, Xiaoyu Du, Yechun Xu, Yongqiang Deng, Meiqin Liu, Yao Zhao, Bing Zhang, Xiaofeng Li, Leike Zhang, Chao Peng,[...]. Nature 2020
11

The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro.
Xi Wang, Ruiyuan Cao, Huanyu Zhang, Jia Liu, Mingyue Xu, Hengrui Hu, Yufeng Li, Lei Zhao, Wei Li, Xiulian Sun,[...]. Cell Discov 2020
113
11

The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro.
Xi Wang, Ruiyuan Cao, Huanyu Zhang, Jia Liu, Mingyue Xu, Hengrui Hu, Yufeng Li, Lei Zhao, Wei Li, Xiulian Sun,[...]. Cell Discov 2020
52
11

The epidemiology, diagnosis and treatment of COVID-19.
Pan Zhai, Yanbing Ding, Xia Wu, Junke Long, Yanjun Zhong, Yiming Li. Int J Antimicrob Agents 2020
330
11

Of chloroquine and COVID-19.
Franck Touret, Xavier de Lamballerie. Antiviral Res 2020
296
11


Drug Development and Medicinal Chemistry Efforts toward SARS-Coronavirus and Covid-19 Therapeutics.
Arun K Ghosh, Margherita Brindisi, Dana Shahabi, Mackenzie E Chapman, Andrew D Mesecar. ChemMedChem 2020
99
11

Clinical Outcomes and Plasma Concentrations of Baloxavir Marboxil and Favipiravir in COVID-19 Patients: An Exploratory Randomized, Controlled Trial.
Yan Lou, Lin Liu, Hangping Yao, Xingjiang Hu, Junwei Su, Kaijin Xu, Rui Luo, Xi Yang, Lingjuan He, Xiaoyang Lu,[...]. Eur J Pharm Sci 2021
66
11

Repurpose Open Data to Discover Therapeutics for COVID-19 Using Deep Learning.
Xiangxiang Zeng, Xiang Song, Tengfei Ma, Xiaoqin Pan, Yadi Zhou, Yuan Hou, Zheng Zhang, Kenli Li, George Karypis, Feixiong Cheng. J Proteome Res 2020
56
11

Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants.
Muhammad Tahir Ul Qamar, Safar M Alqahtani, Mubarak A Alamri, Ling-Ling Chen. J Pharm Anal 2020
342
11

Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19.
Richard T Eastman, Jacob S Roth, Kyle R Brimacombe, Anton Simeonov, Min Shen, Samarjit Patnaik, Matthew D Hall. ACS Cent Sci 2020
263
11

Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
Hongchao Pan, Richard Peto, Ana-Maria Henao-Restrepo, Marie-Pierre Preziosi, Vasee Sathiyamoorthy, Quarraisha Abdool Karim, Marissa M Alejandria, César Hernández García, Marie-Paule Kieny, Reza Malekzadeh,[...]. N Engl J Med 2021
839
11

COVID-19: Drug Targets and Potential Treatments.
Carmen Gil, Tiziana Ginex, Inés Maestro, Vanesa Nozal, Lucía Barrado-Gil, Miguel Ángel Cuesta-Geijo, Jesús Urquiza, David Ramírez, Covadonga Alonso, Nuria E Campillo,[...]. J Med Chem 2020
124
11

Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic.
Carsten Weiss, Marie Carriere, Laura Fusco, Ilaria Capua, Jose Angel Regla-Nava, Matteo Pasquali, James A Scott, Flavia Vitale, Mehmet Altay Unal, Cecilia Mattevi,[...]. ACS Nano 2020
145
11


Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19.
Khan Sharun, Kuldeep Dhama, Shailesh Kumar Patel, Mamta Pathak, Ruchi Tiwari, Bhoj Raj Singh, Ranjit Sah, D Katterine Bonilla-Aldana, Alfonso J Rodriguez-Morales, Hakan Leblebicioglu. Ann Clin Microbiol Antimicrob 2020
55
11

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
Chaolin Huang, Yeming Wang, Xingwang Li, Lili Ren, Jianping Zhao, Yi Hu, Li Zhang, Guohui Fan, Jiuyang Xu, Xiaoying Gu,[...]. Lancet 2020
11


Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2.
Qihui Wang, Yanfang Zhang, Lili Wu, Sheng Niu, Chunli Song, Zengyuan Zhang, Guangwen Lu, Chengpeng Qiao, Yu Hu, Kwok-Yung Yuen,[...]. Cell 2020
11

Coronavirus membrane fusion mechanism offers a potential target for antiviral development.
Tiffany Tang, Miya Bidon, Javier A Jaimes, Gary R Whittaker, Susan Daniel. Antiviral Res 2020
292
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.